iQONE HEALTHCARE SWITZERLAND IN BRIEF
iQone Healthcare Switzerland focuses on the following therapeutic areas: oncology and immunology. We are one of the
market leaders in Switzerland’s , in biosimilars for Infliximab. The expertise of our Speciality pharma lies in biosimilars
and is supported by our high-quality service, namely:
- next-day delivery,
- invoices in the language of your choice,
- option for dedicated hospital batches,
- datamatrix on all products for complete information,
- unique full traceability using data matrices,
- proven therapeutic quality, recognized safety and reliability.